Objectif
With the support of EIC funding, Thirona aims to transform their innovative thoracic AI imaging system, LungQ, into an end-to-end clinical decisions support system (CDSS) called LungQ-Care. The current information workflow of thoracic imaging makes it exceedingly complicated to personalise lung treatments. However, LungQ-Care tackles this challenge by enabling radiologists to quantify medical imaging and disease phenotypes to deliver structured analyses to lung doctors. This empowers them to interpret medical imaging effectively and offer personalised treatments to their patients for optimal disease management while reducing costs. LungQ displayed clinical impact by reducing anaesthesia induced bronchoscopic interventions by 81.5% for COPD cases. Additionally, LungQ reduces the time to analyse cystic fibrosis images from days to minutes. With medical and technical expertise, Thirona has the capabilities to lay the foundation for a scalable and ground-breaking AI platform in lung care.
Champ scientifique
Mots‑clés
Programme(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Régime de financement
HORIZON-EIC-ACC-BF - HORIZON EIC Accelerator Blended FinanceCoordinateur
6525EC Nijmegen
Pays-Bas
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.